UnitedHealthcare
Tavalisse (fostamatinib)
Drugs for the Blood : Drugs for the Blood
  • Immune Thrombocytopenic Purpura (ITP):
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Diagnosis Types: Chronic Immune Thrombocytopenia
    Reauthorization Requirements Documented in Policy: Show Response
    Supporting Documentation Must Be Submitted: No

  • Step Therapy: Immune Thrombocytopenic Purpura (ITP):
    ST Single Generic

  • Prior Authorization: Immune Thrombocytopenic Purpura (ITP):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Quantity Limit: limit maximum 2 EA PER 1 day(s)